Propel Bio Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Propel Bio Management, LLC disclosed 16 US equity positions worth $82.4m in its Q2 2025 13F filing. The largest position was PAGPEUR at 30.0% of the reported book, followed by ACHV and AKERO THERAPEUTICS INC. Against the Q1 2025 filing, it opened 2 new positions, added to 5 and reduced 2 among the top 16 holdings.
What did Propel Bio Management, LLC own in Q2 2025? Top 16 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PAGPEUR PLAINS GP HOLDINGS LP-CL | 30.0% | $24.7m | 1,272,360 | 0% | held | |
| 2 | ACHV ACHIEVE LIFE SCIENCES INC | 16.9% | $13.9m | 6,153,091 | 151% | added | |
| 3 | AKERO THERAPEUTICS INC | 14.8% | $12.2m | 228,884 | 0% | held | |
| 4 | PHAT PHATHOM PHARMACEUTICALS I | 10.7% | $8.9m | 922,927 | -19% | reduced | |
| 5 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 6.7% | $5.5m | 974,022 | 56% | added |
| 6 | APLT APPLIED THERAPEUTICS INC | 4.3% | $3.5m | 11,285,420 | 0% | held | |
| 7 | MIST MILESTONE PHARMACEUTICALS | 4.2% | $3.5m | 1,791,557 | 23% | added | |
| 8 | DCTH DELCATH SYSTEMS INC | 3.7% | $3.1m | 226,052 | 27% | added | |
| 9 | TCRX TSCAN THERAPEUTICS INC | 3.7% | $3.0m | 2,087,139 | 0% | held | |
| 10 | ZVRA ZEVRA THERAPEUTICS INC | 2.5% | $2.0m | 231,874 | 29% | added | |
| 11 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 0.8% | $695.1k | 70,000 | – | new |
| 12 | MAAT PHARMA SACA | 0.5% | $452.1k | 94,181 | -43% | reduced | |
| 13 | ATHIRA PHARMA INC | 0.5% | $450.8k | 1,492,792 | 0% | held | |
| 14 | 72C EIGER BIOPHARMACEUTICALS | 0.5% | $423.0k | 146,381 | 0% | held | |
| 15 | WTS - Achieve Life Sci | 0.0% | $13.7k | 3,699,999 | – | new | |
| 16 | CHINOOK THERAPEUTICS | 0.0% | $2.5k | 79,357 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.